2012Medical Innovation of ChinaRequires access

Clinical Study of the Protective Effect of Reduced Glutathion Infusion Combined with Calcium/Magnesium on Oxaliplatin-inducedChronic Neurotoxicity

Jian Cheng

Open publisher page 0 citations

Abstract

Objective :To investigate whether the administration of calcium/magnesium(Ca/Mg) infusion combined with Glutathione(GSH)infusion can reduce Oxaliplatin-related neurotoxicity.Method :Patients after FOLFOX4 chemotherapy were randomized into treatment group and controlgroup,and received calcium/magnesium infusion and Glutathione infusion(treatment group,n = 26) or placebo(control group,n = 24). The incidenceand severity of Oxaliplatin-induced neurotoxicity after four cycles were observed. Result :After four cycles of chemotherapy,26.7%(7/26) of patients intreatment group were observed gradeⅡ-Ⅲ neurotoxicity while 58.3%(14/24) in control group were. The incidence of neurotoxicity in grade Ⅱ-Ⅱwassignificantly different between the two groups( 字2=4.361,P0.05).Conclusion :The therapy of calcium/magnesium infusion combined with Glutathioneinfusion is able to reduce the incidence of Oxaliplatin-induced neurotoxicity.

About this research paper

What this paper is about

Objective :To investigate whether the administration of calcium/magnesium(Ca/Mg) infusion combined with Glutathione(GSH)infusion can reduce Oxaliplatin-related neurotoxicity.Method :Patients after FOLFOX4 chemotherapy were randomized into treatment group and controlgroup,and received calcium/magnesium infusion and Glutathione infusion(treatment group,n = 26) or placebo(control group,n = 24). The incidenceand severity of Oxaliplatin-induced neurotoxicity after four cycles were observed. Result :After four cycles of chemotherapy,26.7%(7/26) of patients intreatment group were observed gradeⅡ-Ⅲ neurotoxicity while 58.3%(14/24) in control group were. The incidence of neurotoxicity in grade Ⅱ-Ⅱwassignificantly different between the two groups( 字2=4.361,P0.05).Conclusion :The therapy of calcium/magnesium infusion combined with Glutathioneinfusion is able to reduce the incidence of Oxaliplatin-induced neurotoxicity.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective :To investigate whether the administration of calcium/magnesium(Ca/Mg) infusion combined with Glutathione(GSH)infusion can reduce Oxaliplatin-related neurotoxicity.Method :Patients after FOLFOX4 chemotherapy were randomized into treatment group and controlgroup,and received calcium/magnesium infusion and Glutathione infusion(treatment group,n = 26) or placebo(control group,n = 24). The incidenceand severity of Oxaliplatin-induced neurotoxicity after four cycles were observed. Result :After four cycles of chemotherapy,26.7%(7/26) of patients intreatment group were observed gradeⅡ-Ⅲ neurotoxicity while 58.3%(14/24) in control group were. The incidence of neurotoxicity in grade Ⅱ-Ⅱwassignificantly different between the two groups( 字2=4.361,P0.05).Conclusion :The therapy of calcium/magnesium infusion combined with Glutathioneinfusion is able to reduce the incidence of Oxaliplatin-induced neurotoxicity.

Key concepts: Oxaliplatin, Neurotoxicity, Medicine, Magnesium, Calcium, Glutathione, Chemotherapy, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study of the Protective Effect of Reduced Glutathion Infusion Combined with Calcium/Magnesium on Oxaliplatin-inducedChronic Neurotoxicity — Research Paper | ScholarLens